Table 3 Gastrointestinal symptom scores of PD patients before and after intervention with probiotics and placebo.

From: Probiotic treatment induces changes in intestinal microbiota but does not alter SCFA levels in peritoneal dialysis patients—a randomized, placebo-controlled trial

Parameter

Probiotics group

Placebo group

P1

P2

PRJ

PRF

PLJ

PLF

Pain

5 (3,7)

3 (3,5)

4 (3,6)

4 (3,5)

0.245

0.694

Reflux

2 (2,2)

2 (2,2)

2 (2,3)

2 (2,3)

0.763

0.296

Indigestion

12 (8.25,15)

4 (4,7)

12 (9,15)

7 (5,11)

0.819

0.014*

Diarrhea

4 (3,5)

3 (3,3)

4 (3,5)

3 (3,3)

0.341

0.812

Constipation

7 (5,9)

3 (3,5)

6 (5,9)

5 (4,8)

0.552

0.006*

GSRS scores

32.5 (26.25,37.75)

18 (16,21)

29 (26,35)

22 (17,33)

0.373

0.047*

  1. PLJ, baseline of placebo group; PLF placebo group after intervention; PRJ, Probiotics baseline; PRF, after probiotics intervention. P1 Comparison between PRJ and PLJ. P2 Comparison between PRF and PLF. *, P < 0.05 indicates statistically significant differences.
Back to article page